Endometrial Cancer Trial, Recruiting NCT05848557 Sponsor: Duke University Condition: Endometrial Cancer
Back to Endometrial Cancer

Endometrial Cancer Trial, Recruiting

NCT05848557
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For healthcare workers (including community health volunteers, clinic staff, supervisors, and Ministry of Health officials):

  • People who are 18 years of age or older
  • People who are employed by a government clinic
  • People who are currently working in cervical cancer screening

For women (general participation and surveys):

  • Women between 30 and 65 years old
  • Women who live within Siaya County, in one of the study communities
  • Women whose eligibility for cervical cancer screening meets the Kenya Ministry of Health guidelines (confirm with trial site)
  • For some parts of the study, women who have an intact cervix and uterus

For community health volunteers in Aim 2 and the R33 phase:

  • People employed by government clinics in Siaya County
  • People who are able to give informed consent

Who may not be able to join:

  • People who do not understand the purpose and details of the study
  • People who are not willing to sign an informed consent form

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 919 613 5062

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
19 February 2024
Est. completion
30 June 2027

Where this trial is recruiting

Kenya

Primary endpoints

Number of Community Health Volunteers (CHVs) reporting a usability score greater than 60; Proportion of women in each arm who complete cervical cancer screening; Proportion of women in each arm who test HPV-positive and access treatment within 3 months of receiving their results; Difference in women's knowledge level of cervical cancer as measured by a knowledge scale between the arms; Difference in women risk perception of cervical cancer as measured by a risk perception scale between the arms; Difference in Community Health Promoter (CHP) screening self-efficacy, knowledge, usability between...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov